Mitophagy in Alzheimer's disease and its potential as a therapeutic target

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Damaged mitochondria accumulate in neurodegenerative diseases like Alzheimer's disease (AD).
• Mitophagy, a selective mitochondrial clearance process, is implicated in AD pathogenesis.
• Deficits in mitophagy can create a cycle with amyloid-beta (Aβ) and Tau pathologies, leading to neuronal death.

Purpose of the Study:

• To elucidate the molecular mechanisms of mitophagy in AD.
• To explore the dual role of mitophagy in ferroptosis within AD.
• To highlight mitophagy as a therapeutic target for AD intervention.

Main Methods:

• Review of current literature on mitophagy, mitochondrial dysfunction, and AD.
• Analysis of molecular pathways involving mitophagy, NLRP3 inflammasome, Aβ, Tau, and ferroptosis.
• Synthesis of evidence linking mitophagy deficits to AD progression and neuroinflammation.

Main Results:

• Mitochondrial dysfunction exacerbates AD by activating the NLRP3 inflammasome.
• Mitophagy modulation can reduce neuroinflammation in neurons and microglia.
• Mitophagy plays a complex, dual role in pathological ferroptosis in AD.

Conclusions:

• Mitophagy is a critical factor in AD pathogenesis, influencing neuronal survival and inflammation.
• Targeting mitophagy presents a promising therapeutic avenue for Alzheimer's disease.
• Understanding mitophagy mechanisms is key to developing effective AD interventions.